This page introduces the management and Board of Directors of Majelco Medical, Inc. as well as the advisory, consultancy and legal team.
The Company’s Officers, Board Members, consultants and advisors have extensive experience in the life sciences and medicine, including direct experience in medical device development, as well as finance, marketing and business development.
Majelco Medical, Inc. is a privately held, prototype-stage medical device company focusing on the development and commercialization of new proprietary methods of measuring blood loss during surgery.
The Company was founded in 2014 with the mission to bring much higher precision to infusion and transfusion practices in the operating room, saving patient and provider costs, and significantly improving patient outcomes.
The Company continues to seek complimentary business relationships, out-license opportunities and co-development opportunities.
Our company includes a team of senior medical professionals and bioengineers, as well as strong, eperienced business leaders with substantial experience in life science technology business development.
Management & Directors
MICHAEL RUSSELL, MBA
Chief Executive Officer and Board Member
Mr. Russell has spent over 27 years in the medical device industry developing and managing initiatives for Fortune 100/500, early stage and start-up companies. He served in areas of increasing responsibility for Pfizer, Bard, Stryker, Medtronic, and Maquet, achieving top performance awards for each of the companies he was with.
He then joined a start-up device company serving as Executive VP for Inceptio Medical Technologies. At this company, he helped raise capital and developed and launched multiple product lines while managing global business growth for the portable ultrasound and disposables manufacturer. Furthermore, he was instrumental in preparing this company for acquisition in less than 2 years.
Subsequently, Mr. Russell served as founder and CEO for a medical device company servicing the US market in areas of surgical implants, vascular access, and medical diagnostics before becoming an industry strategy consultant. Since then, he has been successful in various executive management roles working with multiple early stage and start-up medical device, product, and service companies.
His expertise in developing and launching new technologies to market of new device companies, coupled with his executive leadership capabilities has enabled him to be instrumental in helping multiple new companies achieve profitability for the first time. He has extensive industry experience and a strong relationship base with the most prominent hospital network organizations and teaching institutions throughout the world, as well as with national Group Purchasing Organizations (GPO’s), Integrated Delivery Networks (IDN’s), and managed care and governmental organizations.
Mr. Russell received an MBA from Westminster College with certificates in Marketing and International Administration, and a BS in Economics from the University of Utah. He resides in Utah with his family where he enjoys staying active in the great outdoors with family and friends when time permits.
ANNETTE MACINTYRE, MD, FRCPC
Chief Medical Officer and Chairman of the Board
Annette MacIntyre, MD, FRCPC, is a board certified anesthesiologist with 30 years of clinical experience at university hospitals in Canada and the USA.
She is fellowship trained in Anesthesia for Vascular Surgery at the University of Ottawa and was Head of Anesthesia for Vascular Surgery at Dalhousie University in Halifax, Canada. Most recently, she was an Associate Professor of Anesthesiology at the University of Utah. After years of frustration in the OR, because she could never be sure of her patients’ precise blood loss, she decided to develop the HemoptixTM technology for accurate, real-time blood loss measurements.
Dr. MacIntyre was born and raised in Munich, Germany, but has lived all of her adult life in Canada and the USA. She is very happily married to Rob MacLeod, PhD, a bioengineering professor at the University of Utah, who has inspired her to pursue her interest in the development of anesthesia related technology for the improvement of patient care. In her free time, she loves to travel and has explored many different cultures around the world. When not traveling, she hikes, bikes and skis in the Great Outdoors with her husband and her family.
Chief Financial Officer, Secretary, Treasurer
Mr. Chou is responsible for (a) participation in the planning and execution of business, financial and business development strategies; (b) the management of Company finances, corporate governance and treasury matters, including accounting and disbursements; and (c) the execution of corporate development activities, including capital generation.
Mr. Chou’s corporate experience includes serving as a Chief Financial Officer, Controller, and CEO, as well as a management consultant for numerous companies. He is a founding partner of Spectra Consulting Group, where for over 25 years he has performed consulting on growth issues in emerging businesses, including specialized consulting in strategic planning, cash management, capital structures, dispute mediation, and organizational re-engineering and process development.
He is a serial entrepreneur, business owner and currently serves as an officer of several operating life science, technology and consumer product companies and sits on various Boards as a Board Member. He has participated in architecting numerous capital structures and has developed strategies for development-stage enterprises that have produced significant debt and/or equity investment.
Chou’s clients are located across the western United States and in the Asian region. A Minnesota native, Mr. Chou is an affiliate of the Association for Conflict Resolution and Utah Dispute Resolution.
RICHARD (DICK) CLAYTON, JD
Mr. Clayton has spent over 30 years starting, financing and operating businesses in a multitude of industries, including renewable energy, electric vehicles, technology, manufacturing and mining.
Most recently, he was a founder of electric vehicle manufacturer VIA Motors, Inc. and has served at various times as COO, CFO and General Counsel. He formerly served as Executive Vice President and General Counsel of renewable energy developer Raser Technologies, Inc.
At these two companies he took a leading role in arranging for more than $850 million in public and private equity and debt, as well as major operating roles. Mr. Clayton also has more than 15 years experience with major law firms serving the needs of a broad range of clients.
From 1989-1999, he was a senior executive with publicly-traded Geneva Steel where his experience included $1.3 billion in corporate finance transactions, project construction and finance, domestic and international acquisitions, international trade, distribution and logistics, environment, energy, and public policy.
He has significant experience in corporate governance matters as well as public and private fundraising for entities ranging from technology startups to large publicly traded multi-national manufacturers. Mr. Clayton has testified before the International Trade Commission and lobbied at the federal and state levels on environment, trade, energy, transportation and tax matters. He holds a JD, as well as Bachelor’s degrees in Accounting and Finance, from the University of Utah. He also held a CPA certificate (Utah) from 1978-1981.
DEREK SAKATA, MD
Dr. Sakata is a Professor and Vice Chair of Anesthesiology at the University of Utah. He currently holds a Leland O. and Avanelle W. Learned Endowed Professorship in Anesthesiology. He is Director of Anesthesia services for the John Moran Eye Center and holds an adjunct associate professorship of ophthalmology. He further has an adjunct associate professorship of bioengineering. He presently is founder and chief of the CRNA Care Team at the University of Utah. He also is founder of Anecare LLC and Dynasthetics LLC. He is currently the Chief Medical Director for Dynasthetics LLC.
Dr. Sakata received his Bachelor of Science degree in electrical and computer engineering from the University of California, Irvine and his medical degree from Loma Linda University, Loma Linda, CA. Further, he completed an internship at Arrowhead Regional Medical Center, Colton, CA and a residency in anesthesiology at the University of Utah School of Medicine in Salt Lake City, UT. He served as chief resident in his final year of residency at which time he decided to continue as faculty at the University of Utah.
R. TYLER MCCABE, MPH, PhD
Director – Engineering R&D and Board Member
Dr. McCabe is currently President and CEO (Director and Co-Founder) of J3 Bioscience, Inc., a medical device company focused on improving women’s health. He is the overall corporate executive strategy leader, as well as the driver for technology development, clinical/regulatory activities, and product commercialization. He has over 26 years of experience as an executive manager, leader, and entrepreneur in the medical device and pharmaceutical industry. Dr. McCabe has a strong background in program and project management and supervising multi-functional teams and scientific personnel to progress lead products through vertically integrated development processes from laboratory to clinical human trials and regulatory clearance. His extensive experience includes leading teams in interactions with industry and academic collaborators, as well as significant interface between preclinical, clinical, regulatory, business/corporate development, and marketing groups involving medical devices and pharma products. Dr. McCabe successfully transitioned numerous products from discovery through preclinical testing and FDA clearance/approval.
He is skilled in interacting with scientific groups, management, Board of Directors, advisors, key thought leaders, and investors. Dr. McCabe is also an Adjunct Assistant Professor in the Department of Bioengineering at the University of Utah.
Previously, he held executive positions including CEO of MyGene International, USA (SLC, UT), VP R&D and Scientific Affairs of Cognetix, Inc. (SLC, UT), and VP R&D of Pharmaceutical Discovery Corporation (Elmsford, NY) (now MannKind, NASDAQ: MNKD). In addition, he was a PRAT Fellowship Awardee and Staff Fellow at the National Institutes of Health (Bethesda, MD) for his post-doctoral work. He also has worked in various capacities with numerous companies including Medtronic, Inc., ARYx, ZARS, MacroMed (now Protherics), Echelon, LineaGen, Durect, and Xsira.
Dr. McCabe has the following educational background: PhD, Pharmacology and Toxicology, University of Utah School of Medicine and College of Pharmacy, 1987; PhD Thesis/Visiting Scientist, Department of Pharmacology and the Brain Research Institute, UCLA School of Medicine, 1986; Master of Science Public Health (Epidemiology), University of Utah School of Medicine, 1986; BS, Behavioral Science and Health, University of Utah, 1982. Dr. McCabe has published 110 scientific articles, including 41 peer-reviewed manuscripts and 69 additional scientific reports, abstracts, and book chapters. He is an inventor on 17 issued patents.
LARA BREWER, PhD
Director – Bioengineering R&D, Founder
Dr. Brewer, co-founder and former officer and member of the Majelco Medical Board, has 17 years of engineering consulting experience for medical device companies such as Philips Medical, Laerdal, and Respironics. She has supported several medical device projects through the complete product development cycle from idea generation to market. Her experience includes diverse areas such as upstream marketing, prototype design and development, animal and clinical testing, and FDA and report submissions.
Dr. Brewer is also a Research Assistant Professor in the Department of Anesthesiology at the University of Utah, with an adjunct appointment in the Department of Bioengineering. Lara’s research interests include oxygen generation for pediatric patients in low resource countries, breath monitoring for patients receiving opioids for pain relief, clinical decision support and alarm systems, pharmacodynamic interactions and modeling gas exchange. Dr. Brewer has received high profile grant funding from the Bill and Melinda Gates Foundation and the Anesthesiology Patient Safety Foundation, with other grant support from NIH, DOD, and NASA. Dr. Brewer is also an active member and former Director At-Large for the Society for Technology in Anesthesia.
AARON DUFFY, PhD
Technology Advisor, University of Utah Technology & Venture Commercialization
Dr. Duffy represents the University as a technology manager at the University of Utah’s Technology & Venture Commercialization with the Health Sciences team.
After earning his Doctorate from the University of Alabama at Birmingham in biochemistry and molecular genetics, Dr. Duffy joined a small Utah biotech company as a research scientist. While in product and assay development, he gained a passion for working with intellectual property and exploring new commercialization strategies. This led him to join the Technology & Venture Commercialization’s Economic Development team as a Data Analyst. As an analyst for the Engineering team, and later the Health Sciences team, he consistently demonstrated acumen in defining the potential for commercializing and protecting a diverse array of University of Utah inventions.
DAVID BESHEARS, PhD
Consultant, Optical Measurement Engineering
Dr. Beshears is President & CEO of Emerging Measurements Company (EMCO) a boutique, high-tech company consulting and contracting with government and commercial entities to solve specialized, challenging measurement problems relating to photonics-based measurement systems utilizing Lasers, LEDs fiber optics and Thermographic Phosphor engineering.
He is a senior engineering researcher and Project Manager with strong leadership and relationship building skills. Has strong background in specialized instrumentation utilizing lasers and fiber optics. Has worked on projects for/or with the Oak Ridge National Lab’s Spallation Neutron Source, Department of Energy, National Security Organization, Armed Services (Air Force, Army, Marines, and Navy), National Aeronautic and Space Administration (NASA), Defense Advanced Research Projects Agency (DARPA), American Iron and Steel Institute, and other commercial entities. Has experience in Uranium Enrichment technology using both Gas Centrifuges and the Gaseous Diffusion technology. President of a small high tech business doing consulting and contracting with government and commercial entities to solve challenging measurement problems.
JAMES U. JENSEN, JD, MBA
Mr. Jensen is CEO of ClearWater Governance Group. He was previously a founder and served on the board of Intelisum, and also previously a founder, director and CEO of Exeven Therapeutics Corp. He also served on the board of directors of the University of Utah Research Foundation.
Mr. Jensen served for twelve years on the Board of NPS Pharmaceuticals, and as Vice President, General Counsel and Secretary from its founding in 1986 to 2004, guiding NPS through multiple financings, technology partnerships and merger transactions valued at more than $600 million. He previously served as an outside director to InterWest Home Medical. He has served as outside counsel then as CFO to Cericor, prior to it being sold to Hewlett-Packard, and he was General Counsel of Dictaphone Corporation. He was the founder and first president of the MountainWest Capital Network and was a founder, board member and first legal counsel to the Utah Ronald McDonald House. He was the first chairman of the Utah Chapter of the National Association of Corporate Directors. Jim lectures widely on technology and corporate governance and has taught university courses on computer law and entrepreneurship. He has authored and published articles on confidential disclosure agreements and on splitting the roles of the CEO and board chairman in high technology start -up companies.
Mr. Jensen holds JD and MBA degrees from Columbia University.
RICHARD (DICK) CLAYTON, JD
Please see Mr. Clayton’s profile under Management & Directors.
JOSEPH P. ANDERSON III, JD
Associate Patent Attorney
Mr. Anderson is a member of the Mechanical Technologies (including Medical Device and Ornamental Design) Team in the firm’s Patents Group. He has particular experience in advising clients on infringement risks, and design changes in advance of large-scale product launches in the industrial, consumer product, and medical device technology sectors. Mr. Anderson also has extensive experience in opinion preparation, client counseling, and patent portfolio analysis.
Mr. Anderson has widespread experience in preparing, filing, and prosecuting utility and design patent applications, both domestically and internationally. His representative technologies include catheters, surgical systems and tools, prosthetics, tissue products, heart valves, medical imaging, drilling systems and methods, packaging materials and systems, agricultural equipment, flooring products, control panel assemblies, pipe couplings, delivery vehicles, conveyor systems, and orthopedics.
He is registered to practice before the United States Patent and Trademark Office. He received his B.E. from Vanderbilt University in 2004, and obtained a JD from the University of Alabama School of Law in 2008.
FRANK W. COMPAGNI, JD
Partner, Patent Attorney
As a founding partner of the firm Mr. Compagni has prepared and prosecuted patents in all areas of art including mechanical, chemical, biotech, electrical, software and business methods, and has significant experience in trademark and copyright matters.
In addition, he has successfully represented his clients in enforcing their intellectual property rights as well as defending his clients that have been accused of infringing the intellectual property rights of others. He has also prepared, negotiated and enforced licensing and manufacturing agreements, product development agreements, non-disclosure agreements and other technology-related contractual matters for his clients. Mr. Compagni has additional experience in preparing patentability, infringement and right-to-use opinions as well as performing due diligence analyses for intellectual property acquisitions.
In addition to assisting his U.S.-based clients in protecting their foreign intellectual property rights, Mr. Compagni represents many foreign clients in pursuing their U.S. patent and trademark rights. As such, he has substantial experience in preparing and filing international patent and trademark applications and nationalizing and prosecuting foreign patent and trademark applications domestically.
Before practicing law, Mr. Compagni had several years of engineering experience working for such companies as Hercules, Inc., Thiokol, Corporation and Rockwell International, Collins Defense Communications Division.
He is registered to practice before the United States Patent and Trademark Office. He received his BS from the University of Utah, and obtained a JD from the University of Utah School of Law.